Biopharmx Corporatio (BPMX) 2.50 $BPMX Cleavage vs.

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biopharmx Corporatio (BPMX) 2.50 $BPMX

Cleavage vs. Cover-up: New Study Sponsored By Violet® iodine Reveals 73 percent of American Women Aren't Looking to Show-off 'The Girls'
PR Newswire - Wed Jul 08, 8:22AM CDT
If you've got them, flaunt them, right? Well, that's now only true for 27% of American women according to a new survey conducted by Newlio for Violet® iodine. In fact, this summer, the top swimsuit choice will be a one-piece (51 percent), followed by a tankini (18 percent), and a bikini (13 percent). Modesty may be on the rise this season, but the majority of women (73%) are perfectly happy with their cup sizes.
BPMX: 2.50 (+0.05)

BioPharmX Corporation Closes Underwritten Public Offering of Common Stock
PR Newswire - Wed Jul 01, 6:00AM CDT
BioPharmX Corporation (NYSE MKT: BPMX) today announced the closing of its previously announced underwritten public offering of 3,636,364 shares of its common stock at a price to the public of $2.75 per share. BioPharmX has granted the underwriters a 30-day option to purchase up to 545,454 additional shares of common stock at the public offering price.
BPMX: 2.50 (+0.05)

U.S. IPO Weekly Recap: Year's Hottest Deal Pops 186% In Year's Most Active Week With 13 IPOs
Renaissance Capital IPO Research - at Seeking Alpha - Sat Jun 27, 11:49AM CDT
Things just got Seres in the IPO market. Thirteen companies went public this past week , more than any week since October 2014. Seres Therapeutics skyrocketed 186% on its debut - the highest first-day pop since January 2014. The thirteen IPOs...
XTLY: 8.29 (+0.04), TRU: 24.45 (+0.12), CATB: 14.38 (+1.83), GNRT: 13.62 (-0.06), GPP: 14.89 (+0.60), GKOS: 30.75 (+0.51), APPF: 14.79 (+0.68), YECO: 5.09 (+0.42), MCRN: 19.76 (+0.28), LNTH: 6.91 (-0.09), BPMX: 2.50 (+0.05), ALRM: 16.15 (-0.30), MCRB: 40.90 (+1.06)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Jun 25, 11:45AM CDT

CNXR: 11.57 (+0.90), TROV: 9.63 (+0.20), CNR: 1.00 (-0.01), CVSL: 1.18 (+0.06), NR: 7.91 (+0.08), SSE: 3.45 (-0.26), ATAI: 4.65 (+0.08), KIQ: 2.75 (-0.09), OPGN: 3.43 (+0.08), DSKX: 3.18 (-0.05), TRU: 24.45 (+0.12), HCA: 92.97 (+1.33), THC: 59.43 (+0.48), ISSC: 3.00 (unch), IKGH: 2.02 (-0.10), DPW: 0.93 (-0.02), SIXD: 12.20 (+1.33), BPMX: 2.50 (+0.05), OGEN: 1.62 (+0.04)

BIOPHARMX CORPORATION UPLISTS TO NYSE MKT (BPMX)
PR Newswire - Thu Jun 25, 6:00AM CDT
BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company focused on the development of proprietary drug delivery products, today announced the pricing of a public offering of 3,636,364 shares of common stock at a price to the public of $2.75 per share for an aggregate offering amount of $10 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by the company. In addition, BioPharmX has granted the underwriters a 30-day option to purchase up to 545,454 additional shares of common stock at the public offering price. In conjunction with the pricing of the offering, the company is simultaneously uplisting to the NYSE MKT today, and begins trading under the ticker symbol "BPMX." All shares of common stock to be sold in the offering are being offered by BioPharmX. The offering is expected to close on or about June 30, 2015, subject to customary closing conditions.
BPMX: 2.50 (+0.05)

BioPharmX begins trading on the NYSE MKT
M2 - Thu Jun 11, 12:15PM CDT
Companies mentioned in this article: BioPharmX Corporation (OTCQB: BPMX), DAVIDsTEA Inc. (NASDAQ: DTEA), Evolent Health Inc. (NYSE: EVH), EndoChoice Holdings (NYSE: GI), and PennTex Midstream Partners, LP (NASDAQ: PTXP)
DTEA: 20.51 (+1.31), EVH: 19.65 (-0.09), BPMX: 2.50 (+0.05), PTXP: 18.95 (-0.03), GI: 15.09 (+0.09)

BioPharmX on deck for IPO
Seeking Alpha - at Seeking Alpha - Thu Jun 11, 12:06PM CDT

BPMX: 2.50 (+0.05)

BioPharmX to uplist to the NYSE MKT, via APO, while PennTex is the next IPO
M2 - Tue Jun 02, 8:26AM CDT
Companies mentioned in this article: BioPharmX Corporation (OTCQB: BPMX), Source Financial Inc. (SRCF), PennTex Midstream Partners, LP (NASDAQ: PTXP), Memorial Resource Development Corp. (NASDAQ: MRD), and Shopify Inc. (NYSE: SHOP)
SHOP: 29.60 (+0.54), MRD: 17.62 (-0.16), BPMX: 2.50 (+0.05), PTXP: 18.95 (-0.03)

BioPharmX Corporation Announces Violet(TM) Iodine is Now Available at The Vitamin Shoppe®
PR Newswire - Mon Apr 20, 7:00AM CDT
BioPharmX Corporation (OTCQB: BPMX), makers of Violet(TM) iodine, the new, once-daily, non-prescription iodine supplement for the relief of premenstrual breast discomfort*, today announced that new Violet iodine is now available at The Vitamin Shoppe®.
BPMX: 2.50 (+0.05)

BioPharmX Corporation Files Registration Statement For Proposed Public Offering
PR Newswire - Thu Apr 09, 4:37PM CDT
BioPharmX Corporation (OTCQB: BPMX), a specialty pharmaceutical company focused on the development of proprietary drug delivery products, today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed public offering of its common stock. The number of shares to be offered by BioPharmX and the price range for the offering have not yet been determined.
BPMX: 2.50 (+0.05)

BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors
PR Newswire - Mon Mar 30, 8:30AM CDT
BioPharmX Corporation (OTCQB: BPMX), a specialty pharmaceutical company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced the appointment of Stephen Morlock, a seasoned financial executive and retail industry veteran, to its board of directors. Mr. Morlock's background will assist the company as it continues to expand its national roll-out of Violet iodine, the new, once-daily, non-prescription pill for relief of premenstrual breast discomfort, and he will serve as an independent board member on BioPharmX Corporation's audit, compensation and nominating and corporate governance committees.
BPMX: 2.50 (+0.05)

BioPharmX Corporation Completes Pre-IND Meeting With U.S. FDA To Review Its Topical Acne Solution
PR Newswire - Wed Mar 18, 7:00AM CDT
BioPharmX Corporation (OTCQB: BPMX), a specialty pharmaceutical company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that its planned pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (FDA) was held on March 11, 2015, as scheduled. The pre-IND meeting focused on the company's topical antibiotic acne compound currently under development and the company's proposed strategy for advancing its acne program and plans for conducting safety and toxicology studies, along with human clinical trials.
BPMX: 2.50 (+0.05)

BioPharmX Announces Violet(TM) Iodine Now Available at Leading National Retailer
PR Newswire - Tue Mar 10, 7:00AM CDT
BioPharmX Corporation (OTCQB: BPMX), makers of Violet(TM) iodine, the new, once-daily, non-prescription pill for the relief of premenstrual breast discomfort, today announced the first-of-its-kind product has added a major U.S. drugstore chain to its retail partners. The daily supplement is available now and will be offered exclusively in the feminine care aisle.
BPMX: 2.50 (+0.05)

BioPharmX names Michael Hubbard as chair of audit committee
M2 - Fri Jan 30, 2:10AM CST
Biotechnology company BioPharmX (OTCBB:BPMX) disclosed on Wednesday the addition of Michael Hubbard as a new independent member of its board of directors, increasing the board's total number of members to four.
BPMX: 2.50 (+0.05)

BioPharmX Corporation Appoints Michael Hubbard To Its Board Of Directors
PR Newswire - Wed Jan 28, 10:30AM CST
BioPharmX Corporation (OTCQB: BPMX), a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced the appointment of Michael Hubbard as a new independent member of its board of directors. Hubbard, a seasoned financial executive with a career in public accounting and auditing, will also lead the company's audit committee. Hubbard's appointment brings the board's total number of members to four.
BPMX: 2.50 (+0.05)

BioPharmX Corporation Granted Pre-IND Meeting With U.S. FDA To Review Its Topical Acne Solution
PR Newswire - Mon Jan 12, 9:00AM CST
BioPharmX Corporation (OTCQB: BPMX), a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that it has been granted a pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration to discuss the company's topical antibiotic acne compound currently under development. The meeting, currently scheduled for March 2015, is expected to focus on the company's proposed strategy for advancing its acne program and plans for conducting safety and toxicology studies, along with human clinical trials.
BPMX: 2.50 (+0.05)

BioPharmX Corporation To Present At OneMed Forum SF 2015 Conference
PR Newswire - Thu Jan 08, 9:00AM CST
BioPharmX Corporation (OTCQB: BPMX), a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that Jim Pekarsky, chief executive officer and co-founder of BioPharmX, will present at the OneMed Forum SF 2015 Conference on Monday, January 12 at 3:00 p.m. PST at the Marriott Marquis in San Francisco.
BPMX: 2.50 (+0.05)

UPM Pharmaceuticals to Manufacture BioPharmX's First Commercially Available Product
PR Newswire - Wed Dec 10, 8:00AM CST
UPM Pharmaceuticals, a division of Gregory Pharmaceutical Holdings, Inc., has reached an agreement with BioPharmX, Inc. (OTCQB: BPMX) to commercially manufacture solid dose iodine supplement tablets for the consumer products sector. The tablets will be manufactured at UPM's 475,000 square-foot manufacturing facility in Bristol, Tennessee, under a commercial supply agreement. Terms of the agreement were not disclosed.
BPMX: 2.50 (+0.05)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Navan’s Travel Survey Sells Friction as a Business Case

Updated Category News Views 154

A forgotten charger can turn a routine trip into a small mutiny. That is the useful little truth sitting underneath Navan’s new survey of 2,000 Americans who travel for leisure or business. The company is poking at the annoyances people carry from the bedroom packing pile to the jet bridge: forgotten items, rushed airport arrivals, pre-flight drinks, chatty strangers,...

Continue Reading
SecureSpace Plants a Fifth Flag in Miami Beach Storage

Updated Category News Views 111

A small box on Alton Road may carry outsized weight Miami Beach does not hand out cheap, easy real estate wins, which is why SecureSpace's opening at 633 Alton Road deserves a closer look than its modest footprint might suggest. The newly rebranded SecureSpace Miami Beach facility has 18,358 square feet of traditional storage and locker space spread across 536 units, plus...

Continue Reading
Docusign Pushes Contract Data Into ChatGPT Sales Tools

Updated Category News Views 187

Contracts are where sales momentum goes to get lost, buried under old PDFs, approval chains, and somebody’s half-finished CRM note. Docusign’s November 17, 2026 launch is a sensible attempt to drag that information into the place sellers may increasingly spend their working day: ChatGPT for Sales. The company’s new plugin lets a sales rep pull agreement intelligence...

Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks

Updated Category News Views 196

Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...

Continue Reading
ELEGOO's Formnext Push Tests a Broader 3D Ambition

Updated Category News Views 123

Frankfurt’s show floor is where product promises meet some very unforgiving eyeballs. ELEGOO arrived at Formnext 2026 with more than a refreshed machine or two: it is laying out a wider bet across resin printing, FDM printing, and 3D scanning. That matters because the company is no longer presenting itself as merely a supplier of affordable creator hardware. It wants to...

Continue Reading
AMPERA Joins Berto to Power Future Energy Innovations

Updated Category News Views 172

The Power Play You Didn't See Coming AMPERA and Berto just made a move that could stir up some serious waves in the energy sector. They've inked a business combination deal set to push advanced energy technology to the forefront. With AMPERA's valuation clocking in at roughly $900 million, this partnership aims to bring cutting-edge power solutions from concept to market....

Continue Reading
Kobo and CloudLibrary Make Library Ebooks Much Easier

Updated Category News Views 107

A tiny button can change whether a digital service gets used Borrowing an ebook ought not feel like assembling a radio in a dark garage, yet that is roughly where library reading has landed for plenty of people. OCLC's new CloudLibrary integration with Kobo strips out a particularly annoying step: U.S. and Canadian users can link accounts once, borrow a title, and have it...

Continue Reading
MAXHUB's Canon Office Test Puts Hybrid Work on Trial

Updated Category News Views 68

Thirty-nine devices scattered through a new Hong Kong office may not sound earth-shaking, but this is how workplace technology actually earns its keep: not under trade-show lights, but when somebody is late to a meeting in another time zone and the room has to work anyway. MAXHUB and Canon Hong Kong have launched the first officially delivered Co-Create 100 project...

Continue Reading
STORMER LAT Targets Sewer Crews' Costly Access Delays

Updated Category News Views 65

A buried cleanout can turn a simple sewer inspection into a scheduling circus. That unglamorous headache is exactly where FIBERSCOPE is aiming its new STORMER LAT Lateral Launch Camera System, announced November 17, 2026. This is not some flashy consumer gadget hunting for attention; it is field equipment built around a painfully ordinary municipal problem: crews often...

Continue Reading
VisionX AI Bets on Graphs to Track Crypto Crime Nets

Updated Category News Views 74

Money laundering rarely travels in a straight line, and that is precisely the sore spot VisionX AI is trying to jab. The Singapore-based RegTech company has introduced AEGIS, a proprietary Large Graph Model built around financial-crime networks, alongside TraceX, a blockchain investigation platform meant to turn that network view into usable leads. It is a sensible...

Continue Reading

Top 5 Most Recently Viewed Articles

Rocket Lab USA's Earnings Predictions and Market Insights

Updated Category News Views 157

Earned Expectations from Rocket Lab USA Rocket Lab USA (NASDAQ: RKLB) is gearing up for its quarterly earnings report, anticipated by investors with curiosity and optimism. The forthcoming announcement promises to deliver crucial insights into the company's financial health and growth trajectory. Expected Earnings Snapshot Analysts forecast that Rocket Lab will register...

Continue Reading
Upcoming Q2 Financial Results Announcement from Parkland

Updated Category News Views 108

Exciting News from Parkland Corporation Parkland Corporation, known for its dedication to providing quality fuel and convenience products, is gearing up for its next financial milestone. The company anticipates unveiling its second quarter results for 2025, a pivotal moment for investors and stakeholders alike. Key Announcement Details Scheduled to be disclosed after the...

Continue Reading
FLSmidth Secures Major Flotation Technology Contract for Iron Ore

Updated Category News Views 201

FLSmidth Secures Major Flotation Technology Contract for Iron Ore A leading Indian miner and steel producer has made a significant decision by selecting FLSmidth & Co. A/S to deliver a comprehensive flotation technology package for their state-of-the-art iron ore beneficiation plant. This facility is poised to be among the largest and most efficient of its kind globally,...

Continue Reading
Arthur J. Gallagher & Co. Plans Financial Results Conference

Updated Category News Views 118

Arthur J. Gallagher & Co. Announces Key Earnings Details Arthur J. Gallagher & Co. (NYSE: AJG) is gearing up to share its financial results for the fourth quarter of 2025. The announcement will be made after market closure on Thursday, January 29, 2026. Following this release, interested investors will find a printer-friendly version on the company’s official website,...

Continue Reading
Exelixis Faces Investor Scrutiny Amid Financial Reporting Concerns

Updated Category News Views 234

Exelixis under Investigation by Pomerantz Law Firm Pomerantz LLP, a renowned law firm, has initiated an investigation concerning investors of Exelixis, Inc. (NASDAQ: EXEL). This inquiry focuses on potential securities fraud or other unlawful practices involving the company and its leadership. Insights into Recent Financial Performance Recently, Exelixis reported its...

Continue Reading